We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Ebekozien O, et al. OP 020.

Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...

Please provide your email address to receive an email when new articles are posted on . The use of closed-loop insulin delivery conferred a 10.99% higher time in range than standard of care for ...

Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine ...

Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing ...

Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

Compared with net loss of $130.6 million in Q1 2025 Tandem Diabetes Care plans to file a 510(k) submission with the Food and Drug Administration this quarter for its first tubeless insulin pump. The ...